Loading compound...
DNA topoisomerase I inhibitor
Exatecan is a small molecule drug that works as a DNA topoisomerase I inhibitor. It is currently being studied in clinical trials (Phase 3) and is not yet FDA-approved for general use.
How it worksExatecan works by inhibiting an enzyme called DNA topoisomerase I, which helps stop the growth of certain cells.
Class
Small moleculeDNA topoisomerase I inhibitor
How to take
Exatecan is currently in Phase 3 clinical trials and is not an approved medication for consumer use at this time.
Talk to your doctor
Questions to ask
- ·What stage of clinical trials is Exatecan currently in?
- ·How does Exatecan's mechanism as a DNA topoisomerase I inhibitor work?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
